Buy or sell Cibus stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Cibus Stock

Cibus has developed plant and microbial platforms.

Founded

2001

Notable Investors

Headquarters

San Diego CA, US

Total Funding

$127M

About Cibus Stock

Cibus’ breeding technology works without integrating foreign genetic material, thus the resulting organisms are non-transgenic (non-GM). The Company has developed and patented advanced breeding technologies that enable precise, stable, predictable changes to be made in plants and other organisms without integrating foreign genetic material. Cibus has launched its first crop, SU Canola™, in North America and expects to develop non-transgenic traits in every major crop.

Funding History

July 2017$57.0M
June 2018$70.0M

Management

Senior Vice President & Commercial and Business Development

Bradley Castanho

Chairman

Rory Riggs

Vice President, Finance

Gerard Pilon

Senior Vice President

Sean O'Connor

Vice President, Commercial Development

David Voss

Senior Vice President & Product Development

Jim Radtke

President & CEO

Peter Beetham

Chief Scientific Officer

Greg Gocal

Other Companies

Logo
Cartiva

Cartiva is a developer of innovative products for the treatment of cartilage injuries and osteoarthritis.

Logo
ENDOTRONIX

Endotronix develops miniaturized, wireless, and implantable pressure sensors implanted as part of interventional cardiovascular procedures.

Logo
KelDoc

KelDoc is the leading platform for patients to book appointments in French hospitals and clinics

Logo
Navigenics

Personal genomics

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Cibus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo

Logo